Peak serum ethanol concentrations and time of peak serum ethanol concentrations without additional medication and following metoclopramide (MCP) or N-butylscopolamine (NBS) administration (n = 7)
| Peak serum ethanol concentration (mg/100 ml) | Time of peak serum ethanol concentration (min) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intravenous | Oral | Intravenous | Oral | |||||||||||
| – | MCP | NBS | – | MCP | NBS | – | MCP | NBS | – | MCP | NBS | |||
| 0.31 (0.05) | 0.30 (0.04) | 0.27 (0.07) | 0.23 (0.08) | 0.27 (0.08) | 0.21 (0.06) | 30.0 (0.0) | 30.0 (0.0) | 34.3 (6.8) | 22.9 (11.6) | 29.3 (13.7) | 50.0 (21.2) | |||
Results are expressed as mean (SEM).
Significant differences in peak serum ethanol concentrations were as follows: MCPoral v NBSoral, p=0.0233; NBSoral vcontrolintravenous, p=0.0356.
Significant differences in the time of peak serum ethanol concentrations were as follows: NBSoral vcontroloral, p=0.0371; MCPoral vNBSoral, p=0.0356.